ARCHIVES

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Budget for FY 1977 Would Halt New Research

January 23, 1976

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

NIH Budget Cut At $142 Million, NCI Could Get Small Increase Over 1981 Total; Schweiker Backs NIH Funds

February 27, 1981

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007

NCI Branch Chiefs, ACCI Join Support For DeVita

June 25, 1981